carvedilol has been researched along with Autoimmune Diabetes in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inflammation is one of the main mechanisms of pancreatic β-cell damage and the development of type 1 diabetes (T1D)." | 1.62 | Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress. ( Amirshahrokhi, K; Zohouri, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amirshahrokhi, K | 1 |
| Zohouri, A | 1 |
| Diogo, CV | 1 |
| Deus, CM | 1 |
| Lebiedzinska-Arciszewska, M | 1 |
| Wojtala, A | 1 |
| Wieckowski, MR | 1 |
| Oliveira, PJ | 1 |
2 other studies available for carvedilol and Autoimmune Diabetes
| Article | Year |
|---|---|
Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress.
Topics: Animals; Blood Glucose; Body Weight; Carvedilol; Cyclooxygenase 2; Cytokines; Diabetes Mellitus, Typ | 2021 |
Carvedilol and antioxidant proteins in a type I diabetes animal model.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Blood Glucose; Carbazoles; Carvedilol; Caspase 3 | 2017 |